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Abstract
We investigate the post-translational generation of Gla (γ-carboxy glutamic acid) from Glu
(glutamic acid) by vitamin K carboxylase (VKC) in solvent. VKC is thought to convert vitamin K,
in the vitamin K cycle, to an alkoxide-epoxide form, which then reacts with CO2 to generate an
essential ingredient in blood coagulation, γ-carboxyglutamic acid (Gla). The generation of Gla
from Glu is found to be exergenic (−15 kcal/mol) in aqueous solution with the SM6 method. We
also produced the free energy profile for this model biochemical process with other solvent
methods (polarizable continuum model, dielectric polarizable continuum model) and different
dielectric constants. The biological implications are discussed.
Keywords
vitamin K cycle; Dowd mechanism; free energy profile; solvent; heterodimer
Introduction
Vitamin K plays a key role in the blood coagulation cascade [1, 2]. The vitamin K
carboxylase (VKC) converts the hydroquinone form of the vitamin K to alkoxide-epoxide
form as shown in Figure 1. In that biochemical process, the alkoxide reacts with CO2 to
generate an essential ingredient in the blood coagulation cascade, Gla (γ-carboxyglutamic
acid) from Glu (glutamic acid). Gla assists several vitamin K-dependent blood coagulation
proteins, (factor II, factor VII, factor IX, factor X, protein C and protein S, etc.), to anchor to
anionic lipid membranes in the presence of Ca2+ and thereby trigger and sustain the blood
coagulation cascade [2, 3]. The biochemical process for the generation of Gla by VKC has
been proposed by Dowd [4]. The Dowd mechanism can be characterized as “base
amplification” [4–6] involving the effective deprotonation of a γ-hydrogen and the
generation of a carbanion intermediate in the conversion process of Glu to Gla (Fig. 2).
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Several quantum chemical approaches have been performed on models of the biochemical
processes for the vitamin K cycle [7–10]. Despite promising results, the quantum
calculations have not fully addressed the solvent effect. In this work, we use a more
advanced continuum solvent method, SM6 [11] to investigate the free energy changes
during the vitamin K cycle. For the purpose, we calculate the aqueous solvation free energy,
, of the proposed intermediates in pseudo-enzymatic pathway [4, 7] in the conversion
process of Glu to Gla using SM6. We then obtain the relative free energy change, which
gives a free energy profile in the liquid-phase along the reaction pathway for the conversion
process of Glu to Gla.
In the SM6 method, the aqueous solvation free energy is partitioned into [11]
(1)
The asterisk in the  denotes that the aqueous solvation free energy calculation is
performed for an ideal gas at a gas-phase concentration of 1 mol/L dissolving as an ideal
solution at a liquid-phase concentration of 1 mol/L [11]. ΔEelec is the energy change in the
solute’s internal electronic energy moving from gas-phase to the liquid-phase at the same
geometry and ΔErelax is energy change in the solute’s internal energy because of change in
the geometry accompanying the solvation process [11]. ΔErelax has a finite value only when
the optimization process is performed in liquid-phase. In this study, ΔErelax is set to zero
since the intermediates are used with the geometry optimized in the gas-phase.  is the
concentration change contribution between the gas-phase and the liquid-phase. It is set to
zero as we use the same concentration of 1 mol/L at both phase [11]. ΔGp is the polarization
contribution to the free energy arising from the bulk electrostatic interaction between solute-
solvent. ΔGCDS is an empirical term, which is not included in Gp term. The label “CDS”
stands for cavitation-dispersion-solvent structure. In the SM6 method, the partial charge
calculation approach is updated using the Charge Model 4 (CM4) [11]. The aqueous
solvation free energy for the reaction as shown in Figure 2 is calculated. Thus, the relative
free energy for the reaction pathway for the process of the generation of Gla is obtained.
Methods
All the structures (initial structures are from [7]) were fully geometry optimized using
Gaussian03 [12] with the basis of b3lyp/6-31+g(d,p) (gas-phase). In the model of vitamin K
and its derivatives, the methyl group (R1) and the long hydrophobic side chain (R2) after the
first side chain double bond were replaced by hydrogens [7]. For the aqueous solvation free
energy calculation of the proposed intermediates, the optimized structures were first
obtained in the gas-phase using Gaussian03. Those optimized structures were used as the
initial structures for the liquid-phase calculation according to the SM6 method using
SMxGAUSS [13].
For consistency, the same basis, b3lyp/6-31+g(d,p), was used in both gas-phase optimization
using Gaussian03 and liquid phase single-point calculation using SMxGAUSS. The aqueous
solvation free energy was also calculated using Gaussian03 for two different solvation
models, the polarizable continuum model (PCM)[14] and the dielectric polarizable
continuum model (DPCM).[15, 16] In general, calculated solvation free energies show a
sensitive dependency on the choice of the atomic radii [17]. The default radii in the
Gaussian03 is set to Radii = UA0 (the United Atom Topological Model applied for atomic
radii of the UFF force field)[17, 18]. However, for the improved performance of the
solvation free energy calculation, the Radii = UAHF (the United Atom Topological Model
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for Hatree–Fock) has been recommended [19]. In this work, the default for atomic radii was
changed to Radii = UAHF. The SCFVAC keyword was used in the input file so that the free
energy calculation in the gas-phase is performed before that in the liquid-phase [17].
Results
INITIAL PRODUCT H AND INTERMEDIATE J
The fully energy-optimized structures at the b3lyp/6-31+g(d,p) level (gas-phase) using
Gaussian03 are shown (Fig. S1 in Supporting Information). We obtained the relative free
energy profiles for each of the optimized structures by the SM6, the DPCM, and the PCM
methods. Table I gives the aqueous solvation free energies for the SM6, the DPCM, and the
PCM methods. Figure 3 shows the relative free energy change for the overall model reaction
for the vitamin K cycle in the liquid-phase (ε = 78.3). Our proposed mechanism starts from
the initial material H. It is the simple separated collection of the vitamin K alkoxide-epoxide
(GH), propionic acid (an idealized glutamic acid), and CO2. The loosely bound complex of
alkoxide-epoxide of vitamin K and the protonated glutamic acid model forms the first
intermediate J. The distance between the carbon (numbered as 13 in Fig. S1 in Supporting
Information) and the oxygen of OH group (numbered as 16) in the alkoxide-epoxide form is
1.55 Å. The distance between the oxygen (numbered as 16) and the γ-proton of the glutamic
acid model (numbered as 32) is 2.21 Å. Because of loss of entropy in forming the complex
[7], the free energy change accompanying by the formation of J intermediate shows an
increase of the free energy with respect to the starting material H as shown in Figure 3. In
the DPCM and the PCM method, we obtained ΔGPCM = 8.04 kcal/mol and ΔGDPCM = 9.03
kcal/mol respectively. On the other hand,  was only 2.10 kcal/mol in the SM6 method.
INTERMEDIATE TS1
The OH attachment to the alkoxide-epoxide form of the vitamin K becomes weak and
ultimately unites with a γ-proton of the glutamic acid model to form a water molecule. In
this process, the detached γ-proton leaves behind an anion on the γ-carbon (numbered as 33
in Fig. S1 in Supporting Information) of the glutamic acid model. This carbanion is the key
element in the “base amplification” process. The TS1 intermediate elevates the free energy
with respect to the intermediate J in all the continuum solvents: ΔGPCM = 25.70 kcal/mol,
ΔGDPCM = 15.27 kcal/mol and .
INTERMEDIATE K
The newly formed water molecule is loosely bound to the carbanion carbon of the glutamic
acid model. At this stage, the vitamin K alkoxide-epoxide is almost detached from the
glutamic acid model. The distance between the hydrogen of the water molecule (numbered
as 32 in Fig. S1 in Supporting Information) and the carbanion (numbered as 33 in Fig. S1 in
Supporting Information) is 1.88 Å. The bond between water OH and the γ-carbon becomes
slightly stronger than in the TS1 intermediate (1.90 Å). The free energy of the intermediate
K with respect to the TS1 in both of the PCM and the DPCM methods is decreased: ΔGPCM
= −5.71 kcal/mol and ΔGDPCM = −3.72 kcal/mol. On the other hand,  shows a small
free energy gain of 0.37 kcal/mol. The free energy barriers for the PCM and the DPCM
methods were estimated to be larger than that for the SM6 for TS1 and K—the carbanion
generating stages. For the two intermediates TS1 and K, the ratios of free energy calculated
with DPCM to SM6 were 1.8 (~24.3/13.7 kcal/mol) and 1.5 (~20.6/14.0 kcal/mol)
respectively. Indeed, it has been reported that the DPCM/03 method (implemented in the
Gaussian03) estimated solvation energies with 3.5 larger mean errors for 143 test ions than
for the SM6 method [11, In estimating the mean errors in aqueous solvation free energies
with both SM6 and DPCM/03 models, different basis was used: MPW25/66-31+G(d,p) for
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SM6 and HF/6-31G(d) for DPCM/03.]. In the SM6 method, the formation of the
intermediate TS1 and K may be considered to be the rate-limiting process.
INTERMEDIATE PRETS2
CO2 becomes weakly bound to the hydrated carbanion of the propionic acid. The vitamin K
epoxide is now completely detached from the model Gla. This step leads to reduced free
energy. All of the model free energy values of the intermediate PreTS2 with respect to the K
are decreased: ΔGPCM = −8.27 kcal/mol, ΔGDPCM = −14.40 kcal/mol, and
.
INTERMEDIATE TS2
The carbon in CO2 forms a bond with the carbanion carbon of the glutamic acid model. This
step initiates the addition of CO2 to the glutamic acid model to generate Gla. The change in
free energy of the intermediate TS2 with respect to the PreTS2 for the PCM and the DPCM
methods are ΔGPCM = 2.60 kcal/mol and ΔGDPCM = 3.41 kcal/mol. On the other hand, the
free energy change of the intermediate TS2 for the SM6 method shows a free energy release
of .
INTERMEDIATE POSTTS2 AND FINAL PRODUCT
Through the final two steps (Fig. 2), the final product L [collection of vitamin K epoxide,
H2O, and the negatively charged Gla (−1)] is produced. The relative free energy change
during the vitamin K cycle in the liquid-phase shows that the final product L is more stable
than the initial product H (vitamin K alkoxide-epoxide (GH)+Glu(0)+CO2) by −15.1 kcal/
mol by the SM6 method as shown in Figure 3. The solvent effect can be considered to be the
difference between the ΔGTOTAL for the overall pathway (solvent-vacuum), which is −24.9
kcal/mol and the difference between the barriers of the rate-limiting step, which is −5.5 kcal/
mol. That is, the solvent increases the relative stability of the final state and lowers the
barrier for the reaction.
We also investigated the free energy sensitivity on dielectric constant. Figure 4 shows free
energy profiles in the SM6 methods with dielectric constants of ε = 4.0 and ε = 78.3. Only
the two terms of Eq. 1, ΔEelec and ΔGp, are utilized for the non aqueous system. In case of ε
= 4.0, we found the free energy barrier is 1–2 kcal/mol lower than that of ε = 78.0. Also, we
found the difference between the initial product and final product is reduced in case of ε =
4.0. This was true also for the DPCM and PCM methods (See Fig. S2 and Fig. S3,
respectively, in Supporting Information), although the minimum reaction barrier for these
methods was predicted in vacuum.
To quantify the stability of the final product (L) with respect to the initial product (H)
according to the dielectric constants and the different dielectric solvent methods (SM6,
DPCM, PCM), we defined ΔΔG78.3,4 as
(2)
The values of ΔΔG78.3,4 in the SM6, DPCM, and PCM are listed in Table II.
BIOCHEMICAL IMPLICATION
As shown in Figures 1 and 2, two transmembrane (TM) proteins, VKC, and VKOR, are
involved in the vitamin K cycle oxidation and reduction process, which take places in the
endoplasmic reticulum (ER) of the cell. The alkoxide-epoxide form of the vitamin K is
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recycled into the quinone form after the generation Gla. The recycle process of vitamin K
can be expected to be dependent on the structures of the two proteins as well as their relative
arrangement in the ER membrane. Unfortunately, the structures of these two TM proteins,
VKC, and VKOR, have yet to be characterized even though the sequences have been
determined [20–22]. However, a heterodimer model for these two TM proteins can be
envisioned based on significant biochemical experiments [23–29]. In particular, Lys-218 of
VKC is thought to play a critical role in the deprotonation of the hydroquinone form of
vitamin K and initiation of the carboxylation reaction at the lumen (outer) membrane of
VKC [25].
We used the Philius transmembrane prediction method, which is based on dynamic Bayesian
network [30] and TOPCONS, which is based on a hidden Markov algorithm approach [31]
to predict the location of the TM helices in the sequences of the two proteins. Based on the
prediction results and accumulated biochemical evidences [23–29], we propose a
heterodimer model composed of five TM helices of VKC and three TM helices of VKOR.
We arranged the oxygen (oxy-3 denoted in Fig. 1) of vitamin K to be located near Lys-218
of VKC for the initiation of base amplification. Then, we set the epoxide oxygen, oxy-2
denoted in Figure 1, to be located near the putative active site, Cys-132 and Cys-135 [26], of
VKOR for return of the alkoxide-epoxide form to the quinone form during the vitamin K
cycle.
We obtained negative values for ΔΔG78.3,4 (i.e., approximate from water to lipid) for all
three different dielectric solvent methods (Table II). The implication is that the chemical
process for the generation of Gla in the vitamin K cycle favors aqueous environment rather
than lipid environment. Based on this model, it appears that the biochemical reactions for
generation of Gla would be take place largely in aqueous environment with the lipophilic
tail of vitamin K anchored into the lipid-membrane in vivo (denoted as R2 in Fig. 1). Thus,
we would infer that the overall biochemical reaction (from Glu to Gla) would occur on the
lumen side of the membrane. This speculation, based on our quantum calculations, is
compatible with the experimental finding that Lys-218, involved in the deprotonation of the
hydroquinone form of vitamin K and initiation of the carboxylation reaction of VKC, is
located on the lumen side of the ER membrane [25]. Full details of the heterodimer model
will be presented elsewhere.
Summary
Our model calculation shows that the biochemical process of the generation of Gla from Glu
is exergenic for the SM6 method, indicating an overall spontaneous reaction. Also, the free
energy profile computed by the SM6 method gives an energy barrier (~14 kcal/mol) that is
smaller than that estimated by the PCM and the DPCM continuum solvent methods. The
overall solvent effect of water with the SM6 method is that ΔGTOTAL is more spontaneous
and the rate limiting barrier is decreased. We also estimated the relative free energy profiles
in the liquid-phase with different dielectric constants (ε = 4.0 and ε = 78.3) and with
different dielectric solvent methods (SM6, DPCM, PCM). From these quantum calculations,
we found that the chemical reaction for the generation of Gla in the vitamin K cycle is
predicted to favor an aqueous environment.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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The vitamin K cycle process: two transmembrane (TM) enzymes, vitamin K carboxylase
(VKC), vitamin K epoxide reductase (VKOR), and substrate vitamin K. In the quantum
calculation, R1 and R2 are replaced by hydrogens.
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A proposed mechanism of the generation of Gla from Glu by the vitamin K carboxylase
(VKC). The starting system involves the alkoxide-epoxide form of vitamin K [4] and a
glutamic acid (modeled as propionic acid).
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Relative free energy in the liquid-phase vs. reaction coordinate. The SM6 (ε = 78.3) curve is
produced by performing single-point energy calculations on optimized structures using
SMxGAUSS. Vacuum, DPCM (Dielectric Polarizable Continuum Model), PCM
(Polarizable Continuum Model) curves are generated by performing free energy calculation
on the optimized structures using Gaussian03.
WU et al. Page 10














Relative free energy profiles in the liquid-phase vs. reaction coordinate for different
dielectric environments (SM6) including vacuum.
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TABLE I
The aqueous solvation free energy calculation in the liquid-phase is performed using SMxGAUSS and
Gaussian03 for the three different dielectric solvent models, SM6, DPCM, and the PCM with the same basis
of b3lyp/6-31+g(d,p).
DPCM PCM SM6
ΔGDPCM (kcal/mol) ΔGPCM (kcal/mol)  (kcal/mol)
H2O −7.20 −6.92 −9.24
CO2 0.05 0.06 1.07
GH −25.34 −53.04 −66.92
Gla(−1) −44.61 −67.23 −71.84
Glu(0) −7.51 −6.94 −5.57
J −18.93 −47.05 −65.06
K −20.16 −39.85 −65.12
TS1 −18.40 −36.09 −65.39
PreTS2 −34.10 −48.36 −63.78
TS2 −35.53 −50.60 −61.65
PostTS2 −39.59 −59.61 −70.52
vitamin K epoxide −2.77 −2.05 −8.49
ε
= 78.3 is used as the dielectric constant.
The initial state (H) (Fig. 2) is composed of GH (the vitamin K alkoxide-epoxide model), Glu(0) (modeled by propionic acid), and CO2.
The final state (L) is composed of the vitamin K epoxide, H2O, and Gla(−1).
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TABLE II
ΔΔG78.3,4 (from water to lipid) in the three different dielectric solvent methods.
DPCM PCM SM6
ΔΔG78.3,4 (kcal/mol) −5.90 −3.98 −3.19
Stability of the final product is greater with respect to the initial product according to all of the dielectric solvent methods (DPCM, PCM, SM6).
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